Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Maxcyte Inc (MXCT)

Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 392,529
  • Shares Outstanding, K 104,396
  • Annual Sales, $ 41,290 K
  • Annual Income, $ -37,920 K
  • 60-Month Beta 1.41
  • Price/Sales 9.44
  • Price/Cash Flow N/A
  • Price/Book 1.81
Trade MXCT with:

Options Overview Details

View History
  • Implied Volatility 43.07% ( -54.55%)
  • Historical Volatility 50.27%
  • IV Percentile 21%
  • IV Rank 8.12%
  • IV High 467.20% on 04/05/24
  • IV Low 5.58% on 11/30/23
  • Put/Call Vol Ratio 5.33
  • Today's Volume 38
  • Volume Avg (30-Day) 92
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 823
  • Open Int (30-Day) 577

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.15
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +3.01%
on 07/03/24
5.26 -28.52%
on 06/11/24
-0.68 (-15.32%)
since 06/03/24
3-Month
3.57 +5.32%
on 04/30/24
5.26 -28.52%
on 06/11/24
-0.49 (-11.53%)
since 04/03/24
52-Week
2.45 +53.47%
on 10/05/23
5.55 -32.19%
on 01/12/24
-0.70 (-15.70%)
since 07/03/23

Most Recent Stories

More News
Why Shares of MaxCyte Are Plummeting on Thursday

The biotech company reduced full-year guidance and expects so-so third-quarter revenue.

MXCT : 3.76 (+1.08%)
Nasdaq Futures Slip as Bond Yields Rebound, U.S. Jobs Report Looms

December Nasdaq 100 E-Mini futures (NQZ23) are trending down -0.10% this morning after three major U.S. benchmark indices closed higher on Wednesday as the latest batch of U.S. economic data prompted investors...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
MSFT : 460.77 (+0.32%)
AMZN : 197.59 (-1.21%)
META : 509.96 (+0.09%)
PLTR : 25.85 (+0.08%)
PSX : 140.37 (-0.07%)
MRO : 28.77 (+0.66%)
CALM : 62.16 (+0.55%)
PNDOR.C.DX : 996.400 (+1.74%)
MXCT : 3.76 (+1.08%)
BB : 2.49 (+1.63%)
MaxCyte, Inc. (MXCT) Q2 2022 Earnings Call Transcript

MXCT earnings call for the period ending June 30, 2022.

MXCT : 3.76 (+1.08%)
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022

GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)
MaxCyte, Inc. (MXCT) Q1 2022 Earnings Call Transcript

MXCT earnings call for the period ending March 31, 2022.

MXCT : 3.76 (+1.08%)
MaxCyte Reports First Quarter Financial Results

MaxCyte Increases 2022 Core Revenue Growth Guidance to be at least 25% and Reiterates Milestone Revenue Guidance of $4 million...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)
MaxCyte to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., May 03, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022

GAITHERSBURG, Md., April 20, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.76 (+1.08%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 303.000 (unch)

Business Summary

MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

3rd Resistance Point 3.96
2nd Resistance Point 3.87
1st Resistance Point 3.82
Last Price 3.76
1st Support Level 3.68
2nd Support Level 3.59
3rd Support Level 3.54

See More

52-Week High 5.55
Fibonacci 61.8% 4.36
Fibonacci 50% 4.00
Last Price 3.76
Fibonacci 38.2% 3.63
52-Week Low 2.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar